Profile
| Metric | Value |
|---|---|
| Full Name | Estrella Immunopharma, Inc. |
| Ticker | NASDAQ: ESLAW |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | - |
| Indexes | Not included |
| Website | estrellabio.com |
| Employees | - |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.09 | ||
| Price, 1D Change | +5.76% | |
| - | ||
| - | ||
| - | ||
| -0.95 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| - | ||
| EPS, 1Y Change | - |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | UPTDW | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| - | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.09 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
Revenue
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +12.64% | ||
| - | ||
| - | ||
| - | ||
| 0.00% | ||
| 0.00% | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.09 | ||
| $0.07 | ||
| SMA 200 vs Price | -20.67% | |
| $0.09 | ||
| SMA 50 vs Price | -4.78% | |
| -0.95 | ||
| $0.03 | ||
| 50.57 | ||
| 319.61% | ||
| 333.81% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| - | ||
| - | ||
| - | ||
| -$7.31M | ||
| - | ||
| -$7.31M | ||
| - | ||
| -$7.31M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| - | ||
| 24.65 | ||
| - | ||
| - | ||
| - | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $4.27M | ||
| $4.17M | ||
| $4.45M | ||
| $4.45M | ||
| $180.70K | ||
| $180.70K | ||
| - | ||
| - | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $7.31M | ||
| $7.31M | ||
| - | ||
| $3.20M | ||
| - | ||
| - | ||
| $1,625.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$16.07M | ||
| $4.96M | ||
| $12.79M | ||
| - | ||
| -$16.07M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| No data | N/A | N/A |
Analyst sentiment
Institutional ownership
Screeners with ESLAW
FAQ
What is the ticker symbol for Estrella Immunopharma, Inc.?
The ticker symbol for Estrella Immunopharma, Inc. is NASDAQ:ESLAW
Does Estrella Immunopharma, Inc. pay dividends?
No, Estrella Immunopharma, Inc. does not pay dividends
What sector is Estrella Immunopharma, Inc. in?
Estrella Immunopharma, Inc. is in the Healthcare sector
What industry is Estrella Immunopharma, Inc. in?
Estrella Immunopharma, Inc. is in the Biotechnology industry
What country is Estrella Immunopharma, Inc. based in?
Estrella Immunopharma, Inc. is headquartered in United States
Is Estrella Immunopharma, Inc. in the S&P 500?
No, Estrella Immunopharma, Inc. is not included in the S&P 500 index
Is Estrella Immunopharma, Inc. in the NASDAQ 100?
No, Estrella Immunopharma, Inc. is not included in the NASDAQ 100 index
Is Estrella Immunopharma, Inc. in the Dow Jones?
No, Estrella Immunopharma, Inc. is not included in the Dow Jones index
When does Estrella Immunopharma, Inc. report earnings?
The date for Estrella Immunopharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ESLAW Official Website www.estrellabio.com
- ESLAW Profile on Yahoo Finance finance.yahoo.com/quote/ESLAW
- ESLAW Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/eslaw